| Commodity | Reporter | Partner | Trade flow | Indicator | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
| 3002. Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc | USA | Germany | Imports | Value (US$) | 889,697,248.00 | 1,087,774,055.00 | 1,832,914,241.00 | 1,962,072,121.00 | 2,616,918,226.00 | 3,213,290,299.00 | 6,159,122,330.00 | 8,581,773,521.00 | 12,197,319,611.00 | 12,756,092,057.00 | 8,646,789,785.00 | 11,736,807,531.00 |
| Value Growth, YoY (%) | 34.67 | 22.26 | 68.50 | 7.04 | 33.37 | 22.78 | 91.67 | 39.33 | 42.13 | 4.58 | -32.21 | 35.73 |
The value of imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" to USA from Germany totalled $ 11.7 billion in 2023. Sales of commodity group 3002 to USA from Germany increased by 35% compared to 2022: imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" went up by $ 3.09 billion (the value of sales of commodity group 3002 to USA from Germany was equal to $8.64 billion in 2022)
Imports of commodity group 3002 amounted to 7.2% of total merchandise imports to USA from Germany (in 2023, total imports to USA from Germany were $ 162 billion). The share of commodity group 3002 in total imports to USA from Germany went up by 1.45 p.p. compared to 2022 (it was 5.74% in 2022 and cumulative imports to USA from Germany were equal to $ 150 billion).
Imports of commodity group 3002 accounted for 61% of total imports of group "" to USA from Germany in 2023 (in 2023, the value of imports of commodity group to USA from Germany was $19.1 billion). The share of purchases of commodity group 3002 in total imports of commodity group to USA from Germany increased by 12.9 p.p. compared to 2022 (it was 48% in 2022, and imports of commodity group to USA from Germany accounted for $17.8 billion).
The share of Germany in total imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" to USA amounted to 14.3 percent (11.7 billion USD) in 2023 of 81 billion USD - the value of total merchandise imports of commodity group 3002 to USA in 2023. The share of Germany in imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" to USA increased by 0.974 p.p. compared to 2022 (it was 13.3 percent in 2022, and total imports of commodity group 3002 to USA were equal to 64 billion USD).